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ORIGINAL RESEARCH
Global Psychological Distress and Risk of Atrial Fibrillation Among
Women: The Women’s Health Study
William Whang, MD, MS; Karina W. Davidson, PhD; David Conen, MD, MPH; Usha B. Tedrow, MD, MSc; Brendan M. Everett, MD, MPH;
Christine M. Albert, MD, MPH
Background—-Symptoms of psychological distress and depression have been associated with risk of ventricular arrhythmias and
sudden cardiac death. Their relationship with atrial arrhythmias, however, is less well studied.
Methods and Results—-We sought to assess the long-term relations between psychological distress and risk of atrial fibrillation
(AF) in the Women’s Health Study of female health professionals. We measured psychological symptoms with the Mental Health
Inventory-5. Incident AF was assessed annually and verified through medical records. Among 30 746 women without history of
cardiovascular disease or AF, 771 cases of AF occurred during a median follow-up of 125 months (interquartile range, 117–130
months). Global psychological distress was not associated with AF risk in age-stratified (P=0.61 for linear trend) or multivariable
proportional-hazards models that included antidepressant use (P=0.34). A proxy measure for depression, consisting of Mental
Health Inventory-5 score <53, antidepressant use, or both, was also not associated with AF risk in multivariable models (hazard
ratio=0.99; 95% confidence interval, 0.78–1.25; P=0.93). In post hoc analyses of individual symptoms from the Mental Health
Inventory-5, positive affect, “feeling happy some/a good bit of the time,” was associated with reduced risk of AF (hazard ratio=0.69;
95% confidence interval, 0.49–0.99; P=0.04); other depressive and anxious symptoms were not.
Conclusions—-In this prospective study of women without known cardiovascular disease, global psychological distress and specific
depressive symptoms were unrelated to AF risk. ( J Am Heart Assoc. 2012;1:e001107 doi: 10.1161/JAHA.112.001107.)
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S everal studies have suggested that depression and depres-sive symptoms are associated with ventricular arrhythmia
and with sudden cardiac death.1–5 Atrial fibrillation (AF) is the
most common sustained arrhythmia and confers increased
risks of stroke and cardiac death.6 Although depressive symp-
toms have been associated with increased risk of death among
patients with AF,7 data on the relationship with incident AF are
relatively limited.8,9 The autonomic nervous system is known to
influence the risk of AF, and abnormalities inmarkers of sympa-
thetic and parasympathetic tone have been noted in affective
disorders such as depression and panic disorder.10,11 There-
fore, the autonomic nervous systemmay provide a mechanism
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by which AF is associated with psychological distress such as
depressive symptoms and negative affect. In this study, we
evaluated the relationship between a measure of global psy-
chological distress, the Mental Health Inventory-5 (MHI-5), and
long-term risk of incident AF among a large cohort of healthy
female health professionals.
Methods
All study subjects were participants in the Women’s Health
Study, a randomized trial of low-dose aspirin and vitamin E in
the primary prevention of cardiovascular disease and cancer.
Details of the study design have been published previously.12
Beginning in 1993, 39 876 female health professionals in the
United States, who were ≥45 years of age and free of car-
diovascular disease, cancer, or other major illnesses, were
randomized to receive 100 mg aspirin every other day, 600
IU vitamin E every other day, both, or placebo. Randomized
treatment ended on March 31, 2004, and women were invited
to participate in continued observational follow-up, which was
truncated for the present study at March 10, 2010. Of the
original cohort, 4324 opted out of the observational follow-up
study. These women were excluded from the present analysis
because their AF could not be reliably confirmed.
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On the 60-month questionnaire, global psychological dis-
tress was assessed with the MHI-5, a 5-item subscale of the
Short-Form 36 health status survey.13 Each item asks respon-
dents how much of the time over the past month (all, most, a
good bit, some, little, or none) they felt nervous (anxiety), felt
so down that nothing could cheer them up (depression), felt
calm and peaceful (low affective activation), felt down and blue
(depression), or felt happy (positive affect). The scale is scored
from 0 to 100, with higher scores indicating greater psycho-
logical well-being. The MHI-5 instrument has been shown in
samples based on the general population to have area under
the receiver operating characteristic curve of 0.78 to 0.92 for
mood disorders and 0.71 to 0.74 for anxiety disorders, com-
pared with diagnoses based on psychiatric interviews.14–19 An-
tidepressant use was assessed on the 48-month questionnaire
through an item that asked about any prescription medication
use. Similar to prior studies that used this scale,5,20 we cre-
ated 4 categories of MHI-5 score to indicate severity of global
psychological distress: 86–100, 76–85, 53–75, and <53. We
designated significant psychological distress according toMHI-
5 score <53.5,20 Also, we created a proxy variable for clinical
depression that consisted of MHI-5 score <53, reported an-
tidepressant use, or both.5 In addition to our global assess-
ment, we used individual items from the MHI-5 to assess for
specific relationships between particular symptoms, particu-
larly positive and negative affect, and risk of AF. Responses to
the items were heavily skewed, and we grouped them into 3
categories for each symptom (all or most of the time, a good
bit or some of the time, and little or none of the time).
Because not all data on cardiovascular risk factors were
collected on the 60-month questionnaire, we obtained data
on particular risk factors from the most recent questionnaire
that inquired about them. Data on smoking and alcohol intake
were collected from the 48-month questionnaire, and data on
kilocalories from physical activity were collected from the 36-
month questionnaire.
For the present analysis, we further excluded 2428 women
who did not submit responses on the 60-month questionnaire.
We also excluded 360 women with a history of cardiovascular
disease, 854 women with a history of AF at the 60-month visit
entry, and 1164 women with missing data for the MHI-5. The
final study population consisted of 30 746 women.
Written informed consent was obtained from all partici-
pants. The study was approved by the institutional review
boards of Brigham and Women’s Hospital, Boston, MA, and
Columbia University Medical Center, New York, NY.
Details about the confirmation of AF in the Women’s Health
Study have been reported previously.21 Women who enrolled
in the continued observational follow-up study and who re-
ported an incident AF event on at least 1 yearly question-
naire were sent an additional questionnaire to confirm the
episode and to collect additional information. They also were
asked for permission to review their medical records. For all
deceased participants who reported AF during the trial and
extended follow-up period, family members were contacted to
obtain consent and additional relevant information. An end-
point committee of physicians reviewed medical records for
reported events according to predefined criteria. An incident
AF event was confirmed if there was electrocardiographic evi-
dence of AF or if a medical report clearly indicated a personal
history of AF.
We computed proportions of participants with cardiovas-
cular risk factors according to the baseline presence of af-
fective symptoms, and comparisons were made with Mantel-
Haenszel χ2 tests for trend for categorical measurements
or with analysis of variance for continuous measurements.
We used Cox proportional-hazards models to estimate age-
stratified and multivariable-adjusted hazard ratios (HRs) for AF
associated with MHI-5 category, using the date of return of
the 60-month questionnaire as the starting point for follow-up.
The proportional-hazards assumption was examined by includ-
ing MHI-5 category by logarithm of time interaction terms in
each model, and the assumption was found to be satisfied.
We performed sensitivity analyses in which we reestimated all
Cox models after censoring women at the date of their first
cardiovascular event, defined by myocardial infarction, stroke,
or coronary revascularization. We also performed analyses of
individual symptoms on the MHI-5 and AF by estimating sepa-
rate age-stratified Cox models, with frequency of the symptom
as an ordinal variable (0 = reference, 1 = some or a good bit
of the time, 2 = most or all of the time) and as a categorical
variable.
Results
Among 30 746 women without history of cardiovascular dis-
ease or AF, 2089 (6.8%) had significant global psychological
distress, as represented by MHI-5 score <53 reported on
the 60-month questionnaire (Table 1). Women with signifi-
cant global distress were younger, had higher average body
mass index, and had higher rates of diabetes and hypercholes-
terolemia. Current smoking was more frequent with worse
symptoms of psychological distress, but alcohol intake was
less frequent. Physical activity was lower among women with
more severe symptoms.
During a median follow-up of 125 months (interquartile
range, 117–130 months), there were 771 cases of AF. Com-
pared with women who reported the least global distress,
worse symptoms according to MHI-5 score were not asso-
ciated with risk of AF in age-adjusted or multivariable mod-
els. Table 2 shows HRs for AF in proportional-hazards mod-
els, with and without inclusion of intercurrent cardiovascular
events. In both age-stratified and multivariable analyses that
also included race, body mass index, hypertension, diabetes,
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Table 1. Coronary Heart Disease Risk Factors Among 30 746 Women Without Prior Cardiovascular Disease or AF According to
MHI-5 Category
MHI-5 Category
86–100 (Referent) 76–85 53–75 0–52
No. women (% of total) 11 834 (38.5) 10 696 (34.8) 6127 (19.9) 2089 (6.8)
Age,† mean±SD, y 60.4±7.2 58.6±6.6 57.7±6.2 56.9±6.0
Race, nonwhite, n (%) 506 (4.3) 462 (4.4) 297 (4.9) 83 (4.0)
Body mass index,† mean±SD, kg/m2 26.6±5.1 26.8±5.3 27.2±5.6 27.8±6.1
Diabetes,† n (%) 457 (3.9) 415 (3.9) 280 (4.6) 132 (6.3)
High cholesterol,† n (%) 5212 (44.0) 4741 (44.3) 2875 (46.9) 1022 (48.9)
Hypertension,† n (%) 4784 (40.4) 4327 (40.5) 2611 (42.6) 996 (47.7)
Current smoker,† n (%) 951 (8.1) 1025 (9.7) 713 (11.8) 334 (16.3)
Antidepressant medication, n (%) 439 (3.7) 685 (6.4) 643 (10.5) 430 (20.6)
Alcohol intake, ≥1 drink per day,† n (%) 1390 (11.9) 1194 (11.3) 617 (10.2) 208 (10.2)
Kilocalories of exercise, >1000 kcal/wk,† n (%) 4334 (36.6) 3491 (32.6) 1791 (29.2) 604 (28.9)
Because of missing data, the total number of observations was lower for race (n=30 435), body mass index (n=30 634), alcohol intake (n=30 406), smoking (n=30 420), and
kilocalories of exercise (n=29 368).
∗†P<0.05.
hypercholesterolemia, smoking, alcohol intake, kilocalories
from exercise, randomized treatment assignment, and antide-
pressant use, there was no statistically significant association
between MHI-5 category and AF risk (P≥0.34 for models that
included intercurrent cardiovascular events; P≥0.15 when in-
tercurrent events were censored). When the MHI-5 score was
analyzed as a continuous variable, there remained no evidence
for a linear trend (P=0.79 in age-stratified models) or for a
nonlinear relationship in regression spline analyses (data not
shown).
These results did not materially change when we com-
bined the data from the MHI-5 score with information on
antidepressant use by creating a proxy variable for depres-
sion, consisting of MHI-5 score <53, antidepressant use, or
both. This measure was not associated with risk of AF in age-
stratified (HR=1.09; 95% CI, 0.87–1.38; P=0.44) or multivari-
able (HR=0.99; 95% CI, 0.78–1.25; P=0.93) models that in-
cluded age, race, body mass index, hypertension, diabetes, hy-
percholesterolemia, smoking, alcohol intake, kilocalories from
exercise, and randomized treatment assignment. Models that
focused on MHI-5 <53 and antidepressant use separately also
did not show associations with risk of AF in age-adjusted
or multivariable analyses. Censoring intercurrent cardiovas-
cular events did not materially affect our HR estimates for
depression. In addition, we did not detect statistically sig-
nificant relationships between MHI-5 score and AF risk in
Table 2. Long-Term Relative Risks (95% CIs) of AF Among 30 746 Women Without Prior Cardiovascular Disease or AF According
to MHI-5 Category
MHI-5 Category
86–100 (Referent) 76–85 53–75 0–52 P for Trend (Continuous)
Intercurrent cardiovascular events not censored
No. cases 359 235 129 48
Age stratified 1.0 0.86 (0.73–1.02) 0.91 (0.74–1.11) 1.08 (0.80–1.47) 0.61
Multivariable 1.0 0.87 (0.73–1.03) 0.89 (0.72–1.09) 0.99 (0.72–1.35) 0.34
Intercurrent cardiovascular events censored
No. cases 346 223 118 43
Age stratified 1.0 0.85 (0.72–1.01) 0.86 (0.70–1.06) 1.01 (0.74–1.39) 0.27
Multivariable 1.0 0.86 (0.72–1.02) 0.85 (0.69–1.06) 0.92 (0.66–1.29) 0.15
Multivariable models included age, race, body mass index, hypertension, diabetes, hypercholesterolemia, smoking, alcohol intake, kilocalories from exercise, randomized treatment
assignment, and antidepressant use. Because of missing data, the total number of observations was lower for multivariable models (n=29 983).
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Table 3. Crude Risk of AF in Follow-Up and Age-Stratified HRs for AF According to Specific Items on MHI-5 (N=30 746)
Item No. Women (%) Percentage With AF in Follow-Up Age-Stratified HR (95% CI)
How often have you felt happy?
None/little of the time 1197 (3.9) 3.3 Referent
Some/a good bit of the time 7148 (23.3) 2.2 0.69 (0.49–0.99)
Most/all of the time 22 401 (72.9) 2.6 0.68 (0.49–0.94)
How often have you felt downhearted and blue?
None/little of the time 25 456 (82.8) 2.6 Referent
Some/a good bit of the time 4893 (15.9) 2.2 1.01 (0.82–1.24)
Most/all of the time 397 (1.3) 1.8 0.76 (0.36–1.60)
How often have you been a very nervous person?
None/little of the time 25 029 (81.4) 2.6 Referent
Some/a good bit of the time 5242 (17.1) 2.0 0.90 (0.73–1.11)
Most/all of the time 475 (1.5) 1.9 0.90 (0.47–1.75)
How often have you felt so down nothing could cheer you up?
None/little of the time 27 759 (90.3) 2.5 Referent
Some/a good bit of the time 2713 (8.8) 2.3 1.08 (0.83–1.40)
Most/all of the time 274 (0.9) 1.8 0.82 (0.34–1.99)
How often have you felt calm and peaceful?
None/little of the time 2437 (7.9) 2.3 Referent
Some/a good bit of the time 11 832 (38.5) 2.1 0.92 (0.68–1.23)
Most/all of the time 16 477 (53.6) 2.9 1.00 (0.75–1.32)
proportional-hazards models of subgroups according to race,
hypertension, or diabetes.
In post hoc analyses, we analyzed the relationship between
individual affective symptoms and AF risk (Table 3). In age-
stratified proportional-hazards models with frequency of the
symptom as an ordinal variable, none of the symptoms was
linearly associated with risk of AF in age-stratified models
(P≥0.09). When we analyzed the frequency of individual symp-
toms as a categorical variable, the age-stratified HR for AF was
reduced in women who reported feeling happy some/a good
bit of the time (HR=0.69; 95% CI, 0.49–0.99; P=0.04), or
most/all of the time (HR=0.68; 95% CI, 0.49–0.94; P=0.02).
These results were not attenuated in multivariable analyses.
None of the other symptoms was associated with AF risk.
Discussion
In this analysis of a large cohort of women without cardiovas-
cular disease, history of stroke, or prior AF, a composite global
measure of psychological distress was not associated with AF
risk. With 771 AF events, to our knowledge, ours is the largest
sample of women in whom the relationship between affective
symptoms and AF has been studied. Our analysis adds to the
nascent evidence base on psychological symptoms andAF inci-
dence. Lange and colleagues8 showed in a group of 54 patients
with persistent AF that depressed mood was associated with
greater risk of recurrence after DC cardioversion. In a trigger-
ing analysis that used event monitoring and electronic diaries,
Lampert and colleagues9 observed in 75 patients with parox-
ysmal or persistent AF that arrhythmia episodes were more
likely to be preceded by negative emotions and less likely by
happiness. Our analysis indicates that psychological distress
is not a long-term predictor for AF in women without known
heart disease.
The lack of an association between a proxy measure for
depression (consisting of MHI-5 score <53, antidepressant
use, or both) and AF contrasts with previous findings of an
association between this measure and risk of sudden cardiac
death in women without known heart disease.5 One possi-
ble reason for this null result may involve differences in the
effects of the autonomic nervous system on atrial versus ven-
tricular arrhythmias. Although sympathetic activation is a well-
recognized trigger for ventricular arrhythmias and sudden car-
diac death,22 a substantial proportion of AF appears to be
initiated by parasympathetic triggers, both in animal models23
and in clinical settings.24 In fact, increased heart rate variabil-
ity, which reflects a predominance of parasympathetic versus
sympathetic tone, has been associated with higher risk of re-
current AF after cardioversion.25 Depression has reproducibly
been associated with reduced heart rate variability in patients
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with coronary artery disease,26 and therefore decreased car-
diac parasympathetic modulation might actually reduce the
risk of arrhythmia in certain individuals who are susceptible
to AF. It is also possible that the null result in our study may
be related to a gender difference in psychological predictors
for AF. For instance, findings from the Framingham Offspring
Study showed that baseline levels of tension, anger, and hos-
tility predicted increased 10-year risk of AF in men but not in
women.27,28
When we examined individual items from the MHI-5 that
assessed different types of affect, none of the items that mea-
sured negative affect was associated with AF risk. Neverthe-
less, in a hypothesis-generating finding, reported happiness
some or more of the time was associated with reduced AF
risk. A recent meta-analysis of samples of healthy patients
estimated a reduced risk of all-cause and cardiac death asso-
ciated with positive affect, independent of negative affect.29
Our finding of reduced AF risk in association with greater re-
ported positive affect is intriguing but requires confirmation in
prospective studies.
Several limitations to this study should be mentioned. We
relied on a 5-item self-report instrument to measure psycho-
logical distress and did not have clinical interview data on
psychiatric diagnoses, such that misclassification of depres-
sive symptoms may have biased our findings toward the null
result. However, the MHI-5 has been shown to have high ac-
curacy at identifying individuals with mood disorders and anx-
iety disorders14–16 and has previously been correlated with
cardiac5 and other medical20,30 conditions in large female co-
horts. In addition, we did not have repeated assessments of
psychological distress, so we cannot estimate how risk of AF
relates to changes in distress over time. Our assessment of
AF events depended on participant self-report, with subse-
quent verification by medical records review. If participants
with greater psychological distress were less willing to report
their AF episodes, our estimates of the relationship might be
biased toward a null result. In addition, screening electrocar-
diograms were not performed in this cohort; therefore, it is
possible that asymptomatic cases of AF may have gone un-
detected. Nevertheless, in this cohort of health professionals,
significant underdetection is less likely; a prior analysis in the
Women’s Health Study cohort indicated that 10% of the con-
firmed AF events were asymptomatic.21 Also, our sample was
from a group of women of mostly European ethnic origin, and
we cannot extrapolate these findings to men or to other ethnic
groups.
In summary, in this large prospective study of women with-
out known cardiovascular disease, a global measure of psy-
chological distress was unrelated to AF risk. Future studies
should include standardized and more detailed instruments
of depression and anxiety to test for their association to AF
incidence.
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